| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |